Patents Assigned to AGIRX LIMITED
  • Publication number: 20110002898
    Abstract: The invention relates to tumour therapy. In particular, the present invention relates to vaccine compositions comprising allogenic cells modified with hypercytokines for the treatment of cancer in general and for the treatment of melanoma in particular.
    Type: Application
    Filed: January 30, 2009
    Publication date: January 6, 2011
    Applicant: AGIRX LIMITED
    Inventor: Andrzej MacKiewicz